Algocell

AlgocellAlgocell
Algocell

Algocell

Optimizes bioprocess development using AI-powered digital twins to reduce trial-and-error.

DR 62023Active13Tel Aviv, Israel
Rate

About

Algocell provides an AI-powered platform for bioprocess optimization, enabling the rapid creation of digital twins using hybrid models and advanced AI. Their technology significantly reduces experimental trial-and-error, accelerating development and scale-up for bioprocesses involving yeast, bacteria, and mammalian cells. This empowers pharmaceutical and biotechnology companies to gain deeper insights, optimize productivity, and achieve seamless transitions from pilot to manufacturing.
Frequently asked

What does Algocell do?

Algocell provides an AI-powered platform for bioprocess optimization, enabling the rapid creation of digital twins using hybrid models and advanced AI. Their technology significantly reduces experimental trial-and-error, accelerating development and scale-up for bioprocesses involving yeast, bacteria, and mammalian cells. This empowers pharmaceutical and biotechnology companies to gain deeper insights, optimize productivity, and achieve seamless transitions from pilot to manufacturing.

What is Algocell's revenue?

StartupHub estimates Algocell's annual revenue at $1.9M (range $1.1M to $5.4M, 68% confidence), based on comparable companies in the sector.

Where is Algocell headquartered?

Algocell is headquartered in Tel Aviv, Israel.

When was Algocell founded?

Algocell was founded in 2023.

What industry does Algocell operate in?

Algocell operates in Biotechnology, Healthcare, Artificial Intelligence, Biotech, HealthTech, Drug Discovery.

How many employees does Algocell have?

Algocell has approximately 13 people on record.

HEADCOUNT
13
DOMAIN RATING
6
Comments

No comments yet. Be the first to share your take.